SUTENT is used to treat advanced kidney cancer (advanced renal cell carcinoma or RCC).

To apply for First Resource support, you’ll need an enrollment form. You and
your health care provider must complete it. To get the form, click the link below.
 |
In order to view PDF documents, you must have Adobe® Reader®
installed on your computer. If you do not have Adobe Reader, download it from the
Adobe Web site.
|
Note that the Adobe Web site is neither owned nor controlled by Pfizer. Pfizer is
not responsible for the content or services on that site.
Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated
in the United States and/or other countries.
Pfizer and its agents cannot guarantee the accuracy of information provided by insurers,
nor do they guarantee insurance reimbursement. Because many factors influence reimbursement,
program staff cannot anticipate or resolve all issues raised by program callers.
Pfizer reserves the right to modify or discontinue the program, without notice,
at any time.